ARS Pharmaceuticals, Inc.

NASDAQ
SPRY
Stock
Yield per half year: +3.1%
Dividend yield: 0%
Sector: Healthcare

Share chart ARS Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc., биофармацевтическая компания, разрабатывает методы лечения пациентов и родителей, страдающих тяжелыми аллергическими реакциями. Компания разрабатывает neffy, безыгольный интраназальный назальный спрей с низкой дозой адреналина для пациентов и лиц, осуществляющих уход за ними, с аллергическими реакциями I типа, включая анафилаксию. Компания была основана в 2015 году и базируется в Сан-Диего, штат Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2020-12-04
ISIN US82835W1080
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт link
Цена ао 14.98
Change price per day: 0% (14.98)
Change price per week: +4.54% (14.33)
Change price per month: +8.79% (13.77)
Change price per 3 month: +41.86% (10.56)
Change price per half year: +3.1% (14.53)
Change price per year: +66.82% (8.98)
Change price per 3 year: +359.51% (3.26)
Change price per year to date: +31.29% (11.41)
All parameters

Grade

Underestimation
Title Value Grade
P/S 12.12 1
P/BV 4.21 4
P/E 135.06 1
EV/EBITDA -333.91 0
Total: 3.63
Efficiency
Title Value Grade
ROA, % 2.74 1
ROE, % 3.28 1
Total: 0.8333
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0
Debt
Title Value Grade
Debt/EBITDA -0.0136 10
Total: 8
Growth impulse
Title Value Grade
Yield Revenue, % 400.84 10
Yield Ebitda, % 565.87 10
Yield EPS, % -541.31 0
Total: 5.2
More

Main owners

Institutions Volume Share, %
Deerfield Management Company, L.P. (Series C) 11 077 927 11.69
Orbimed Advisors LLC. 8 740 887 9.22
FMR, LLC 5 088 253 5.37
SR One Capital Management, LP 4 012 903 4.23
Rubric Capital Management LP 3 480 712 3.67
RA Capital Management, L.P. 3 009 678 3.18
K2 Principal Fund, L.P. 2 686 490 2.83
Baker Brothers Advisors, LLC 2 006 451 2.12
Nextech Invest Ag 1 910 029 2.02
Vanguard Group Inc 1 697 637 1.79

Contained in ETF

ETFShare, %Profitability for 1 year, %Dividends, %
Future Tech ETF 0.13757 426.34 0.8416
Principal Healthcare Innovators ETF 0.13757 618.5 0.8416
0.14522.420.84

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL Founder, President, CEO & Director 908.83k 1966 (59 years)
Dr. Sarina Tanimoto M.B.A., M.D. Co-Founder & Chief Medical Officer 748.97k 1969 (56 years)
Mr. Eric Karas Chief Commercial Officer 618.61k 1973 (52 years)
Dr. Robert Bell Ph.D. Co-Founder & Chief Science Officer N/A
Ms. Kathleen D. Scott CPA Chief Financial Officer N/A
Mr. Brian T. Dorsey M.S. Chief Operations Officer N/A 1969 (56 years)
Mr. Alexander A. Fitzpatrick Esq. Chief Legal Officer & Secretary N/A 1967 (58 years)
Mr. Daniel Relovsky Senior Vice President of Marketing N/A
Mr. Justin Chakma Chief Business Officer & Secretary N/A 1990 (35 years)
Mr. Harris Kaplan M.B.A. Executive Vice President of Commercial Strategy N/A 1952 (73 years)

About company

Address: United States, San Diego. CA, 11682 El Camino Real - Open in google maps, Open in yandex maps
Website: https://ars-pharma.com